BMT is an effective therapy for many otherwise lethal diseases including leukemia.
BMT is an effective therapy for many otherwise lethal diseases including leukemia. 1 GVHD is one of the most critical complications accompanying BMT. [2] [3] [4] To reduce the incidence of GVHD, a number of methods have been established in murine and human systems. [4] [5] [6] [7] [8] [9] [10] [11] Elimination of mature T cells from donor BM cells (BMC) is one of the most reliable methods. However, the complete elimination of allogeneic T cells has been shown to increase the frequency of failure of allogeneic engraftment. [12] [13] [14] [15] [16] [17] In addition, it has been reported that GVHD has beneficial effects in preventing recurrence of leukemia via the GVL response. 18 We have reported that BMT mice prepared by inoculation of a small number of T cells with BMC from both MHC class I and non-MHC Ag disparate mice show signs of clinical GVHD at an early stage after BMT. 19 The acute GVHD resulted in abrogation of the thymic negative selection of the self-reactive T cell repertoire. 11, 20 In the present study, using the same experimental BMT system we investigated functions and TCR V␤ repertoires of T cells in the bone marrow chimeras which had recovered from the acute GVHD that had been induced by mismatches at the H-2D and non-MHC loci including minor lymphocyte stimulatory (Mls)-1 locus. The Mls-1 a Ag is an endogenous superantigen and stimulates several repertories of T cells in the absence of priming. 21, 22 We report here a split tolerance of T cells induced in these chimeras. These T cells showed a significant proliferative response but no CTL activity to the recipient cells. To elucidate the mechanism(s) underlying the split tolerance, we analyzed the pattern of cytokine production by these T cells. ) mice were obtained from the Japan SLC, Hamamatsu, Shizuoka, Japan. Five-to 7-week-old female mice were used throughout the study.
Materials and methods

Mice
BMT
Recipient (AKR) mice were lethally irradiated (11 Gy) 24 h before BMT as described elsewhere. 11, 23, 24 To completely deplete mature T cells, donor (B10.A) BMC were treated with anti-Thy1.2 MoAb (F7D5; Serotec, Oxford, UK) plus selected rabbit CЈ (Cedarlane, Hornby, Ontario, Canada). 
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Observation of GVHD signs
Ruffled fur, hunched back, and diarrhea were observed daily as signs of GVHD after BMT. BM chimera mice were weighed at the same time. MLR MLR was performed as described elsewhere. 22, 24, 26 Briefly, spleen cells were passed over nylon wool columns to purify T cells. To evaluate the response to Mls-1 a Ag or H-2 Ag, the purified T cells (3 ϫ 10 5 ) and various kinds of stimulator spleen cells (5 ϫ 10 5 ) which had been treated with 25 g/ml mitomycin C (Kyowa Hakko Kogyo, Tokyo, Japan) for 30 min were cocultured in 200 l of RPMI 1640 supplemented with 10% FCS, 0.1 mm non-essential amino acids solution, 1 mm sodium pyruvate, 100 U/ml penicillin, 100 g/ml streptomycin, 2 mm l-glutamine, 10 mm Hepes buffer and 0.05 mm 2-ME on a 96-well flat-bottom culture plate (Falcon; Becton Dickinson, Franklin Lakes, NJ, USA). After 4 days, cell cultures were pulsed with 18.5 kBq 
CTL assays
Effectors were prepared by MLC where splenocytes (3 ϫ 10 6 /well) from chimeric mice or B10.A mice were cultured for 5 days with AKR splenocytes (2 ϫ 10 6 /well) that had been treated with mitomycin C as described above on 24-well flat-bottom plates (Falcon). AKR splenocytes (target cells) were stimulated with 2 g/ml Con A (Sigma) for 48 h, and labeled for 60 min with 3.7 MBq of 51 Cr (NEZ-030S; New England Nuclear, Boston, MA, USA). After washing three times, the target cells (5 ϫ 10
3 ) were incubated in a 96-well U-bottom culture plate (Falcon) with effectors at effector-to-target ratios (E:T) of 100:1, 50:1, 25:1 and 12.5:1 for 4 h before harvest.
51
Cr release was measured using a gamma counter (Packard). 27 Spontaneous release was calculated from targets incubated in medium alone. Maximal release was calculated from targets treated with 1 n HC1. Percent specific release was calculated using the following formula: (experimental release Ϫ spontaneous release)/(maximal release Ϫ spontaneous release) ϫ 100.
Stimulation of T cells with immobilized anti-CD3⑀ (2C11)
To immobilize anti-CD3⑀, 50 l of purified anti-mouse CD3⑀ (Biosource International, Camarillo, CA, USA) in PBS (10 g/ml) was incubated in 96-well flat-bottom plates at 4°C, overnight. 28 After washing three times with HBSS, 3 ϫ 10 5 nylon wool-purified splenic T cells were cultured in the plates for 48 h. Then, culture supernatants were collected and IL-4 and IFN-␥ productions were quantitated by ELISA.
ELISA
Amounts of IL-4 and IFN-␥ in the supernatant were quantitated with Cytoscreen TM Immunoassay kit for mouse IL-4 (Biosource International) and IFN-␥ (Biosource International), respectively, according to the manufacturer's protocol. 19 Serum IgG1 and IgG2a levels were determined by ELISA. Purified rabbit anti-mouse IgG MoAb (Zymed, South San Francisco, CA, USA) was diluted in coating buffer (0.1 m NaHCO 3 , pH 9.0) and adsorbed to the wells of 96-well microtiter plates (Costar, Cambridge, MA, USA) at 4°C overnight. Uncoated sites in the wells were blocked with blocking buffer (1% BSA in PBS) for 1 h at room temperature. The wells were washed four times with PBS supplemented with 0.05% Tween-20 (PBS/Tween). The serum samples were diluted and incubated for 1 h at 37°C. Then the wells were washed four times with PBS/Tween, and horseradish peroxidase (HRP)-conjugated rabbit antimouse IgG1 MoAb (Zymed) and IgG2a MoAb (Zymed) were added and incubated for 30 min at 37°C. After the wells were washed, o-phenylenediamine was added. The enzyme reaction was stopped by addition of 10% H 2 SO 4 and the absorbance value of the solution in each well was recorded by using an ELISA plate reader at 490 nm. IgG1 and IgG2a levels were calculated by reference to standard curves of known amounts of purified mouse IgG1 (Chemicon, Temecula, CA, USA) and IgG2a (Chemicon). ϩ chimeras recovered at around 2 weeks after BMT to the level before irradiation (Figure 1b) . Subsequently, the BW of T Ϫ chimeras increased until 100 days. On the other hand, the BW of T ϩ chimeras decreased again from 3 weeks after BMT. Thereafter, the BW increased from 6 weeks and reached the pre-BMT level at 8 weeks. However, the BW of T ϩ chimera mice did not reach the level of T Ϫ chimera mice during the whole period examined (Figure 1b) .
Results
Survival and GVHD signs of chimera mice
Chimerism and proportions of V␤6
ϩ and V␤8. Almost identical results were obtained with T cells from spleens (Table 2) , although in the T Ϫ chimera spleens a substantial proportion of Thy1.1 ϩ (recipient) cells were still present at this stage. These findings are essentially compatible with our previous reports, although thymocytes and spleen cells were analyzed earlier (4-5 weeks) after BMT in these previous studies. (Table 3) . On the other hand, T cells from T ϩ chimeras showed a substantial response to AKR stimulators, although the responsiveness was low as compared to that of normal B10.A mice. Since these T cells mounted no proliferative responses against B10.BR stimulators (data not shown), the target Ag in this MLR appeared to be Mls-1 a . Thus, it 
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Responses of T cells from chimeras against recipient Ag
seemed that V␤6
ϩ T cells in the spleen of T ϩ chimeras (Table 2) It should be noted that splenic T cells of T ϩ chimeras that mounted significant proliferative responses to AKR stimulators (Table 3) showed no CTL activity against the AKR targets at all.
Cytokine production by T cells from T
ϩ and T Ϫ chimeras T cells from T ϩ chimeras responded to AKR stimulators in MLR, but showed no CTL activity against AKR Con Ablasts at all. To elucidate the mechanism underlying this split tolerance, production of IL-4 and IFN-␥ by chimera T cells and T cells of normal B10.A mice was quantitated in the MLR supernatants using ELISA. T cells from T To further elucidate the state of T cells in T ϩ and T Ϫ chimeras, splenic T cells from chimeras and B10.A mice were stimulated with immobilized anti-CD3⑀ MoAb, and amounts of IL-4 and IFN-␥ in the culture supernatants were quantitated. As shown in Figure 3a , splenic T cells from T ϩ chimeras manifested a four-fold increase in production of IL-4 as compared with that of B10.A mice and a 1.5-fold increase as compared with that of T Ϫ chimeras. In contrast, splenic T cells from T ϩ chimeras produced significantly less IFN-␥ than those of B10.A mice and T Ϫ chimeras. These findings on the whole indicate that T cells from T ϩ chimeras shift to the Th2 dominant state.
Isotype of IgG in sera of chimera mice
IL-4 induces class switching to IgG1 or IgE, whereas IFN-␥ induces class switching to IgG2a. 30, 31 We then analyzed serum levels of IgG1 and IgG2a in both kinds of chimeras and B10.A mice by ELISA. Figure 4 shows that the serum level of IgG1 is considerably higher in T ϩ chimeras than those in T Ϫ chimeras and B10.A mice. In addition, serum levels of IgG2a in T ϩ and T Ϫ chimeras were significantly higher than that in B10.A mice. However, no difference was detected in the level of IgG2a between T Ϫ and T ϩ chimeras. Since production of IFN-␥ by splenic T cells of T Ϫ chimeras and B10.A mice was almost at the same level (Figure 3b ), these results suggest that the class switch to IgG2a Ab is not directly associated with T cell ability to produce IFN-␥ in the present system. 
Discussion
In the present study, we investigated the influence of acute GVHD on the subsequent reconstitution of T cell compartment and T cell reactivity in recipients that had recovered from the early GVHD. To recover from acute GVHD in the case of human BMT, some form of therapy is usually required, which is different from experimental BMT in mice. However, it seems important to elucidate the subsequent immunological reconstitution in the recipients, 20 no matter how the recipients have recovered from the GVHD.
AKR recipients of T cell-depleted BMC plus splenic T cells ([B10.A → AKR] T ϩ chimeras) showed signs of GVHD. The overt signs of GVHD waned 8 weeks after BMT. In the thymus and spleen of T ϩ chimeras, substantial proportions of V␤6 ϩ T cells that are reactive to the recipient Mls-1 a Ag in the context of H-2E (MHC class II) molecules were detected. This finding is consistent with our previous reports 11, 20, [23] [24] [25] that acute GVHD abrogated clonal elimination of T cells reactive to the recipient Ag 4-5 weeks after BMT. Furthermore, the present finding indicates that the abrogation lasts for a long period even after overt GVHD has improved. Indeed splenic T cells from T ϩ chimeras showed proliferative response against recipient Ag.
However, no CTL activity against the recipient cells was induced in these T cells when they were stimulated with AKR cells in vitro (split tolerance). In the same culture conditions considerable numbers of CD8 ϩ CTL were generated from spleen cells of normal B10.A mouse. Thus, it seemed that CTL precursors of T ϩ chimeras as well as T Ϫ chimeras were tolerant of H-2D k Ag on AKR cells. In our previous studies 22, 23 we found that activated (AKR) T cells produced Mls-1 a Ag. It was shown that GVHD eradicated residual recipient T cells and that the lack of Mls-1 a producing T cells of the recipient type resulted in failure of elimination of V␤6 ϩ T cells in the GVHD [B10.AQR → AKR] chimeras. 20, 23, 25 Indeed, in the present study a substantial proportion of the recipient T cells were demonstrated in the spleens of T Ϫ chimeras, but not in those of T ϩ chimeras, even 8 weeks after BMT (Table 2) . Thus, the split tolerance observed in the present study suggested that although Mls- k (MHC class I) Ag are expressed on almost all recipient cells. However, our recent study indicated that GVHD abrogated the thymic system itself involved in the negative selection of whole T cell repertoire reactive to donor and/or recipient Ag. 32 A similar observation was reported by Desbarats and Lapp. 33 Thus, it remains uncertain whether CD8 ϩ T cells reactive to H-2D k Ag have been deleted or anergized in T ϩ chimeras. This issue is being investigated in our laboratory.
We would like to postulate an alternative mechanism for the apparent tolerance of CTL against the recipient targets in T ϩ chimeras. Efficient activation of CTL is induced by professional APC that are activated by Th1 cells. 34 On the other hand, Th2 cells inhibit activities of APC and Th1 cells by secreting IL-10. 35, 36 Thus, activation of Th2 cells appears to lead to reduction of CTL activity. In the present study, splenic T cells from T ϩ chimeras produced predominantly Th2 cytokines in MLR stimulated with AKR cells or upon stimulation with anti-CD3⑀ Ab as compared with those from T Ϫ chimeras or normal B10.A mice. Thus, it seemed that splenic T cells of T ϩ chimeras shifted to Th2 dominant state that resulted in no considerable CTL activity against the recipient cells in the spleen cells of T ϩ chimeras during the MLR.
In human, the relationship between chronic GVHD after BMT and Th1 and Th2 cytokine secretion pattern has been unclear. Imamura et al 37 reported elevated serum levels of Th1 cytokines in patients with chronic GVHD, whereas in patients with severe GVHD impaired Th1 and Th2 functions were reported. 38 It was demonstrated by Körholz et al 39 that stimulation with anti-CD3 MoAb of T cells from patients with chronic GVHD resulted in decreased IL-10 and increased IFN-␥ production. In chronic GVHD, increased secretion of Th2 cytokines from splenic T cells and increased serum level of IgG1 and IgE were reported. [40] [41] [42] [43] In the present study, splenic T cells from T ϩ chimeras that recovered from acute GVHD showed Th2 shift. We also found high levels of IgG1 in sera of T ϩ chimeras. In addition, we previously reported that spleen cells from GVHD [B10.AQR → AKR] and [B10.BR → AKR] bone marrow chimeras produced spontaneously high levels of IL-4 at an early stage after BMT. 19 Although the precise mechanism remains unclear, it seems to us that this spontaneous IL-4 production is somehow related to the present findings obtained with [B10.A → AKR] T ϩ chimeras 8 weeks after BMT.
It has been demonstrated that NK-T cells produce quite large amounts of IL-4 very rapidly upon stimulation with anti-CD3. 44, 45 However, in our previous study, 19, 24 no significant population of NK-T cells was detected, but V␤6 ϩ ordinary T cells increased markedly in the spleens and thymuses of GVHD chimeras at an early stage after BMT. These findings suggest that the increased V␤6 ϩ , perhaps CD4 ϩ , T cells are responsible for the Th2 shift. It should be further elucidated what kind of target Ag and what subset of T cells are really responsible for the Th2 shift observed in the AKR recipient mice in order to develop the immunomodulation of BMT patients who suffer from GVHD.
